FEATURES OF RELIEF OF UPPER RESPIRATORY TRACT DISEASES INFECTED WITH COVID-19 IN PATIENTS WITH ENDOCRINOLOGICAL DISEASES
Abstract
Clinical and epidemiological studies conducted during the COVID-19 pandemic
prove the powerful negative impact of comorbid pathology on the severity and
outcomes of SARS-CoV-2 viral infection. Concomitant diseases that are widespread
and negatively affect the course of COVID-19 include cardiovascular diseases and
diabetes mellitus (DM).
The aim of the study was to identify the features of the clinical and metabolic
status and disorders of carbohydrate metabolism in hospitalized patients with the new
coronavirus infection COVID-19 in combination with type 2 diabetes mellitus as the
basis for optimizing glycemia management.
References
References
1. Kaiser UB, Mirmira RG, Stewart PM. Our response to COVID-19 as
endocrinologists and diabetologists. J Clin Endocr Metab. 2020;105(5):dgaa148. Doi:
10.1210/clinem/dgaa148.
2. Boelaert K, Visser WE, Taylor PN, et al. Endocrinology in the time of
COVID-19: management of hyper- and hypo- thyroidism. EurJEndocrinol.
2020;183(1):G33–G39. Doi: 10.1530/EJE-20-0445.
3. Мокрышева Н.Г., Галстян Г.Р., Киржаков М.А., и др. Пандемия COVID-
19 и эндокринопатии // Проблемы эндокринологии. —2020. — Т.66. — №1.
[Mokrysheva NG, Galstyan GR, Kirzhakov MA, et al. Pandemiya COVID-19 i
endokrinopatii. Problemy endokrinologii. 2020;66(1). (In Russ.)].
